Us Drug Regulator
The Exchange has sought clarification from Wockhardt Limited with respect to recent news item captioned "US drug regulator issues warning to Wockhardts Ankleshwar plant.". In this regard, Exchange have advised the Company to provide clarification/confirmation on the news item in detail including
11.11 AM Jan 4th
the development, a company official said they had received a minor observation from the US drug regulator in the month of October and it was not going to have any material impact going forward. Earlier in February, Aurobindo`s Unit VII in Mahaboobnagar district in Telangana received some Form 483 observations
10.21 PM Dec 21st 2016
drug used to treat dry eye disease. The drug is currently undergoing late stage clinical trials (phase III) and about 16 million people in the US itself are believed to have been suffering from dry eye disease.Currently there are two drugs approved by the US drug regulator for this condition. Allergan
1.12 PM Dec 1st 2016
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.